LPTX - Leap Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Leap Therapeutics's activity chart (see below) currently has 30 price targets and 52 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20% with an average time for these price targets to be met of 117.7 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 27-Mar-2025. First documented stock forecast 07-Mar-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 27-Mar-2025

1 years 6 months 28 days ago
(27-Mar-2025)

0/6 (0%)

$2.92 (113.18%)

Buy Since 03-Jun-2021

$9

$6.95 (339.02%)

$11

2 years 7 months 6 days ago
(19-Mar-2024)

0/3 (0%)

$6.8 (309.09%)

Buy Since 17-May-2021

$15

$12.95 (631.71%)

2 years 7 months 7 days ago
(18-Mar-2024)

2/4 (50%)

$12.86 (600.93%)

77

Buy Since 04-Oct-2021

2 years 11 months 5 days ago
(20-Nov-2023)

0/3 (0%)

$30.9 (106.19%)

Buy Since 05-Apr-2022

2 years 11 months 11 days ago
(14-Nov-2023)

0/2 (0%)

$13.21 (348.55%)

Show more analysts

Please expand the browser size to see the chart

What is LPTX (Leap Therapeutics) average time for price targets to be met?

On average it took 118 days for the stock forecasts to be reached, with an average price target met ratio of 20%.

Which analyst most recently updated their price target on LPTX (Leap Therapeutics)?

Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?

has 0 price targets and 0 ratings on LPTX

Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?

Wangzhi Li with the highest potential upside of $77.95

Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?

Steven Seedhouse with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?